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Abstract
The coexistence of psychiatric symptomatology among individuals receiving longer-term treatment
for alcohol use disorders has been well-established; however, less is known about comorbidity among
individuals receiving alcohol detoxification. Using the Brief Symptom Inventory (BSI; Derogatis,
1992), we compared psychiatric symptomatology among 815 individuals receiving short-term
detoxification services with normative data from nonpatients, psychiatric patients, and out-of-
treatment individuals using street drugs. Findings revealed that individuals in the current sample
reported a wide range of psychiatric symptoms with over 80% meeting BSI criteria for diagnosable
mental illness. These BSI scores were significantly more severe than those reported by out-of-
treatment individuals using street drugs and most closely resembled BSI scores reported for adult
psychiatric inpatients. Findings suggest that routine screening for severe mental health symptoms
appears warranted in detoxification units. Such screening would greatly increase the chance that
coexistence of substance use and other psychiatric disorders would be properly addressed in ongoing
treatment.
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1.0 Introduction
Ample documentation exists that the co-occurrence of psychiatric disorders with substance use
disorders is a general and widespread problem in general mental health and substance abuse
treatment settings (e.g., Brems & Johnson, 2004; Havassy, Alvidrez & Owen, 2004;
RachBeisel, Scott, & Dixon, 1999), as well as in the general population (e.g., Kessler et al.,
1997; National Institute on Alcoholism and Alcohol Abuse, 2006; Substance Abuse and Mental
Health Services Administration, 2005). Although varying considerably from study to study
depending on treatment setting, assessment methods, and participant characteristics,
individuals receiving or seeking long-term residential or outpatient alcohol treatment services
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have been found to have very high rates of psychiatric comorbidity (e.g., Castel, Rush,
Urbanoski, & Toneatto, 2006; Johnson, Brems, & Burke, 2002; Watkins et al., 2004). However,
less is known about psychiatric symptomatology among individuals with severe and sustained
alcohol abuse or dependence who are receiving short-term detoxification, but no additional
treatment services. The purpose of this study was to assess the degree of psychopathology as
measured by the Brief Symptom Inventory (Derogatis, 1992) among individuals seeking
detoxification services at a short-term, alcohol detoxification program.
2.0 Method
2.1 Setting and Participants
Data were collected from 815 individuals receiving services at an alcohol detoxification unit
located in Anchorage, Alaska. This unit is designed to provide a four-day intervention to
detoxify individuals from alcohol and to assess them for any additional needed treatment.
Average length of stay for the participants was 4.84 days (SD=1.28). Table 1 provides
demographic information about the 815 participants.
2.2 Instrumentation
Brief Symptom Inventory (BSI; Derogatis, 1992). The BSI consists of 53 symptoms drawn
from the Symptom Checklist-90-R (Derogatis, 1992) and assesses current psychological
symptomatology. Each symptom is rated on a 5-point Likert scale that ranges from not at all
present (0) to extremely present (4) for their existence within the past seven days. The BSI
results in nine subscales (Somatization, Obsessive-Compulsiveness, Interpersonal Sensitivity,
Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation, Psychoticism) and three
global indices of distress (Global Severity Index [number and severity of symptoms], Positive
Symptom Distress Index [intensity of symptoms], Positive Symptom Total [number of
symptoms endorsed in a pathological direction without regard to intensity].
Scoring is accomplished by adding ratings for subscale items and dividing by the number of
items. These mean raw scores can be transformed into T-scores (mean of 50 and standard
deviation of 10) separately for women and men, based on relevant norms tables (adult,
adolescent, inpatient, and outpatient). The following two criteria have been established for
designating a protocol as being positive for diagnosable psychopathology based on adult, non-
patient norms: a) T-score for GSI of 63 or greater, or b) T-scores of 63 or greater on two or
more subscales (Derogatis, 1992). The instrument has demonstrated good psychometric
properties, with adequate reliability and validity (Derogatis, 1992; Morlan & Tan, 1998).
2.3 Procedure
The BSI was completed as part of the detoxification unit's regular intake assessment and after
consumers provided informed consent for treatment and use of data for research and evaluation
purposes; all research procedures were conducted in compliance with the Institutional Review
Board at the University of Alaska Anchorage. The BSI and other intake forms were completed
as soon as staff members believed consumers were sufficiently sober to give consent,
understand instructions, and participate in the assessment process. For most consumers, the
assessment process was completed on the second day of services.
3.0 Results
3.1 Comparisons with Normative Samples
To compare whether the BSI scores obtained for the current sample differed from those of four
normative samples (adolescent non-patients, adult non-patients, psychiatric inpatients, and
psychiatric outpatients) provided by Derogatis (1992), independent two-tailed t-tests were
Johnson et al. Page 2
Addict Behav. Author manuscript; available in PMC 2008 August 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
calculated. Table 2 provides means and standard deviations and Table 3 provides t-test results.
Significant differences (p<.001) were revealed between the current sample and the normative
adult and adolescent non-patients on all but one subscale (adolescent non-patients for
Hostility subscale). On all comparisons, the current sample of individuals receiving alcohol
detoxification treatment services provided more pathological symptom ratings.
The current sample differed significantly from psychiatric outpatients on four of nine subscales
(Somatization, Phobic Anxiety, Paranoid Ideation, and Psychoticism) and two of three global
scales (Global Severity Index and Positive Symptom Total). For all significant differences, the
current sample provided higher ratings than the normative psychiatric outpatient sample. The
current sample differed significantly from psychiatric inpatients only on the Somatization
subscale, on which the current sample provided higher ratings.
3.2 Comparisons with Out-of-Treatment Drug Users Sample
Additional independent two-tailed t-tests were calculated to compare BSI scores obtained from
the current sample with BSI scores from a sample of 582 injection drug-using individuals not
currently in treatment. These out-of-treatment drug users were participants in a NIDA-funded
project designed to determine the effects of a needle exchange program (Fisher, Fenaughty,
Cagle, & Wells, 2003). Additional details about this sample are available in Johnson, Neal,
Brems, and Fisher (2006). Table 2 provides means and standard deviations and Table 3
provides t-test results. Results indicate that all BSI subscales and global indices obtained from
individuals receiving alcohol detoxification treatment services were significantly higher than
scores obtained from out-of-treatment, injection drug-using individuals.
3.3 Positive Diagnostic Indicators
Participants were categorized using the two criteria established by Derogatis (1992; see above)
for identifying protocols as demonstrating diagnosable psychopathology. Table 4 provides the
percentages of participants who had a T-score of 63 or greater on each of the nine SCL-90-R
subscales. Based on the criterion of having T-scores of 63 or greater on two or more subscales,
81.3% of the men and 82.6% of the women were diagnosable with comorbid psychopathology.
Based on the criterion of a GSI T-score of 63 or greater, 75.3% of the men and 75.8% of the
women produced protocols that were sufficiently severe to suggest a diagnosis of comorbid
psychopathology.
4.0 Discussion
Prior research has indicated that substance abusers with severe psychopathology are more
likely to receive treatment at mental health facilities and those with less severe
psychopathology are more likely to receive treatment at substance abuse facilities (Primm et
al., 2000). However, current findings suggest that this conclusion based on prior research may
not be generalizable to individuals in detoxification. The individuals in this sample reported
psychiatric symptoms of great acuity and wide range and an exceedingly high proportion of
the sample (over 80%) met BSI criteria for diagnosable mental illness. Clearly, this suggests
a large proportion of individuals in detoxification suffer from great psychiatric distress that
warrants attention. Further, these findings provide evidence that individuals in alcohol
detoxification are symptomatically significantly different from other individuals who are
abusing or dependent on alcohol and from individuals in the general population or in the
psychiatric population.
The implications of this finding could potentially be far-reaching for agencies providing
detoxification services. It appears crucial to identify additional psychopathology among
individuals in alcohol detoxification as such symptoms are likely to complicate treatment and
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evaluation plans. It may be erroneously assumed by providers that the prime goal of
detoxification services is the initiation of sustained sobriety, and that comorbid psychiatric
symptoms will be relieved on their own, or will significantly diminish, once that objective is
achieved. Rather, more positive overall outcomes are likely if treatment plans are designed to
help alleviate both the alcohol use disorder and any comorbid psychological symptoms (Brems
& Johnson, 1997; Grant et al., 2004). Attention to psychiatric symptoms among individuals in
detoxification may greatly enhance their outcomes both with regard to sobriety and mental
health, especially if detection is timed at the onset of their stay in detoxification and can thus
be considered when additional treatment plans are made.
Based on findings from this study, routine screening for severe mental health symptoms appears
warranted in detoxification units. Individuals identified with high psychiatric distress could
then be assessed more thoroughly through a psychiatric interview, a process that would greatly
increase the chance that true coexistence of substance use and other psychiatric disorders would
be properly addressed in ongoing treatment. Care will need to be taken to understand the
psychiatric symptoms and distress of individuals in detoxification in their greater context of
symptom presentation. Even though BSI-based comorbidity rates are high, it must be
understood that they are not always reflective of definite coexistence of an alcohol use and
other psychiatric disorder for each screened individual. It is possible that some acute mental
health symptoms reported are directly related to the detoxification process and ameliorate upon
successful completion of detoxification. However, ongoing observation during the individual's
stay on the detoxification unit to differentiate temporary from ongoing psychiatric distress will
be crucial to the successful long-term treatment of each individual.
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Table One
Participant Characteristics (N=815)
n %
Gender
  Male 551 67.6%
  Female 264 32.4%
Ethnicity
  African American 53 6.5%
  Alaska Native 283 34.7%
  American Indian/Native American 25 3.1%
  White 418 51.3%
  Other 23 2.8%
  Missing 13 1.6%
Marital Status
  Single 379 46.5%
  Married 100 12.3%
  Living with Partner 10 1.2%
  Separated or divorced 284 34.9%
  Widowed 18 2.2%
  Missing 24 2.9%
Educational Attainment
  Eighth grade or less 26 3.2%
  Less than high school 166 20.4%
  High school graduation or GED 352 43.2%
  Some college 183 22.5%
  College graduation 49 6.0%
  Missing 39 4.8%
Living Arrangements
  Own house or apartment 323 39.5%
  Someone else's house or apartment 150 18.4%
  Shelter 114 14.0%
  Street or outdoors 138 16.9%
  Institutionalized 12 1.5%
  Criminal justice system 11 1.4%
  Other 16 2.0%
  Missing 51 6.3%
Employment Status
  Unemployed, Looking for Work 314 38.5%
  Unemployed, Not Looking for Work 203 24.9%
  Full-Time or Part-Time Job 129 15.9%
  Homemaker 9 1.1%
  Retired 8 1.0%
  Disabled 70 8.6%
  Other 38 4.6%
  Missing 44 5.4%
Age Mean=41.1 SD=9.3 Range=18 - 68
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Table 4
Percentages of Men and Women with T-scores of 63 or Greater on Each of the Nine BSI Subscales and Global Severity
Index
Men Women Overall
Somatization 74.1% 72.0% 73.4%
Obsessive- Compulsive 65.3% 72.0% 67.5%
Interpersonal Sensitivity 60.8% 59.9% 60.5%
Depression 77.0% 68.6% 74.2%
Anxiety 73.7% 73.1% 73.5%
Hostility 42.8% 52.7% 46.0%
Phobic Anxiety 65.3% 64.8% 65.2%
Paranoid Ideation 56.8% 64.4% 59.3%
Psychoticism 70.2% 76.5% 72.4%
Global Severity Index 75.3% 75.8% 75.5%
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